Skip to content

Clinical trials

Terminated Neoplasm Metastasis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Terminated Country / region: Taiwan Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20122
20131
20143
20151
20161
20171
20183
20195
20204
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clovis Oncology, Inc.3
Novartis Pharmaceuticals3
AstraZeneca2
Odonate Therapeutics, Inc.2
Ascendis Pharma Oncology Division A/S1
BeiGene1
Chang Gung Memorial Hospital1
Daiichi Sankyo1
Egetis Therapeutics1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis26
Carcinoma, Non-Small-Cell Lung10
Neoplasms9
Recurrence5
Breast Neoplasms3
Melanoma3
Carcinoma, Hepatocellular2
Carcinoma, Renal Cell2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.